Cargando…
Novel Antibody-Based Proteins for Cancer Immunotherapy
The relative success of monoclonal antibodies in cancer immunotherapy and the vast manipulation potential of recombinant antibody technology have encouraged the development of novel antibody-based antitumor proteins. Many insightful reagents have been produced, mainly guided by studies on the mechan...
Autores principales: | Fuenmayor, Jaheli, Montaño, Ramon F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759200/ https://www.ncbi.nlm.nih.gov/pubmed/24212958 http://dx.doi.org/10.3390/cancers3033370 |
Ejemplares similares
-
Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question
por: Ordóñez-Reyes, Camila, et al.
Publicado: (2022) -
Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy
por: Huang, Michael A., et al.
Publicado: (2015) -
TCR-like antibodies in cancer immunotherapy
por: He, Qinghua, et al.
Publicado: (2019) -
Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy
por: Blanco, Belén, et al.
Publicado: (2021) -
Antibody–drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancer management
por: Sarangi, Sudhir Chandra, et al.
Publicado: (2020)